Physician profile
Michelle Chen
NPI 1184950628
$1,121.54
in general payments reported to CMS, 2019-2025
12 companies · $174 in 2025
The $174 reported for 2025 was more than what 78% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2021: $49.36 · 2022: $118 · 2023: $502 · 2024: $175 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $851.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $851.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $332.85 | 2024-2025 | Ankylos |
| Hemosonics LLC | $150.60 | 2023 | Quantra Qplus System |
| Fisher & Paykel Healthcare INC | $130.39 | 2023 | Fisher & Paykel Healthcare |
| Chiesi USA, INC. | $120.53 | 2023 | Cleviprex |
| Heron Therapeutics, INC. | $118.19 | 2022 | |
| Trevena, INC. | $100.00 | 2023 | Olinvyk |
| Acacia Pharma INC | $49.36 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.57 | 2019 | |
| Ferring Pharmaceuticals INC. | $24.16 | 2019 | |
| Abbvie INC. | $17.71 | 2019 | |
| Boston Scientific Corporation | $16.81 | 2024 | |
| Merck Sharp & Dohme LLC | $16.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.